Hemab Therapeutics Holdings, Inc. Earnings Per Share (Basic)
Hemab Therapeutics Holdings, Inc. (COAG) reported Earnings Per Share (Basic) of -$0.80 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Hemab Therapeutics Holdings, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.80.
- Hemab Therapeutics Holdings, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$23.98.
- Hemab Therapeutics Holdings, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$12.91.
- Hemab Therapeutics Holdings, Inc. earnings per share, basic for the quarter ending 2025-03-31 was -$16.18.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month |
|---|---|---|
| 2026-06-30 | -$0.80 10-Q · filed 2026-08-11 | -$3.00 10-Q · filed 2026-08-11 |
| 2026-03-31 | -$23.98 10-Q · filed 2026-05-21 | |
| 2025-06-30 | -$12.91 10-Q · filed 2026-08-11 | -$29.09 10-Q · filed 2026-08-11 |
| 2025-03-31 | -$16.18 10-Q · filed 2026-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |